HUP0202862A2 - A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény - Google Patents

A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény

Info

Publication number
HUP0202862A2
HUP0202862A2 HU0202862A HUP0202862A HUP0202862A2 HU P0202862 A2 HUP0202862 A2 HU P0202862A2 HU 0202862 A HU0202862 A HU 0202862A HU P0202862 A HUP0202862 A HU P0202862A HU P0202862 A2 HUP0202862 A2 HU P0202862A2
Authority
HU
Hungary
Prior art keywords
loteprednol
antihistamines
pharmaceutical composition
composition containing
novel combination
Prior art date
Application number
HU0202862A
Other languages
English (en)
Inventor
Jürgen Engel
Sabine Heer
Degenhard Marx
Istvan Szelenyi
Original Assignee
Viatris Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh & Co. Kg filed Critical Viatris Gmbh & Co. Kg
Publication of HUP0202862A2 publication Critical patent/HUP0202862A2/hu
Publication of HUP0202862A3 publication Critical patent/HUP0202862A3/hu
Publication of HU229606B1 publication Critical patent/HU229606B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya egy loteprednolt vagy gyógyászatilag tolerálhatóészterét és legalább egy antihisztamint tartalmazó gyógyszerkeverék,amely allergiák és légúti rendellenességek kezelésére vagymegelőzésére használható. Ó
HU0202862A 1999-09-30 2000-09-26 Novel combination of loteprednol and antihistamines HU229606B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947234A DE19947234A1 (de) 1999-09-30 1999-09-30 Neue Kombination von Loteprednol und Antihistaminika
PCT/EP2000/009391 WO2001022955A2 (de) 1999-09-30 2000-09-26 Neue kombination von loteprednol und antihistaminika

Publications (3)

Publication Number Publication Date
HUP0202862A2 true HUP0202862A2 (hu) 2003-01-28
HUP0202862A3 HUP0202862A3 (en) 2003-10-28
HU229606B1 HU229606B1 (en) 2014-02-28

Family

ID=7924100

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202862A HU229606B1 (en) 1999-09-30 2000-09-26 Novel combination of loteprednol and antihistamines

Country Status (19)

Country Link
US (1) US7022687B1 (hu)
EP (1) EP1216046B1 (hu)
JP (2) JP5524438B2 (hu)
AR (1) AR025923A1 (hu)
AT (1) ATE241988T1 (hu)
AU (1) AU7907300A (hu)
BR (1) BR0014312B1 (hu)
CA (1) CA2387398C (hu)
CZ (1) CZ295090B6 (hu)
DE (2) DE19947234A1 (hu)
DK (1) DK1216046T3 (hu)
EE (1) EE04997B1 (hu)
ES (1) ES2199868T3 (hu)
HU (1) HU229606B1 (hu)
MX (1) MXPA02003174A (hu)
PL (1) PL196843B1 (hu)
PT (1) PT1216046E (hu)
TW (1) TWI224968B (hu)
WO (1) WO2001022955A2 (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL369630A1 (en) * 2001-12-05 2005-05-02 Alcon, Inc. Use of a h1 antagonist and rimexolone as a safe steroid to treat rhinitis
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
KR101067795B1 (ko) 2002-08-30 2011-09-27 니코메드 게엠베하 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도
AU2003291497B2 (en) * 2002-11-12 2007-12-20 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
US20060263350A1 (en) * 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
AU2005229006B9 (en) * 2004-03-25 2011-05-19 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
ES2626134T3 (es) 2011-01-04 2017-07-24 Bausch & Lomb Incorporated Composiciones de bepotastina
KR20150011807A (ko) * 2012-05-25 2015-02-02 질리어, 인크. 자일리톨계 항-점액성 조성물과 관련 방법 및 조성물
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
AU6392496A (en) * 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
AU3153797A (en) * 1996-06-04 1998-01-05 Procter & Gamble Company, The A nasal spray containing an intranasal steroid and an antihistamine
JP4453987B2 (ja) * 1997-01-16 2010-04-21 千寿製薬株式会社 点鼻用水性懸濁液

Also Published As

Publication number Publication date
US7022687B1 (en) 2006-04-04
ATE241988T1 (de) 2003-06-15
PL353486A1 (en) 2003-11-17
PT1216046E (pt) 2003-10-31
DE19947234A1 (de) 2001-04-05
EP1216046B1 (de) 2003-06-04
PL196843B1 (pl) 2008-02-29
MXPA02003174A (es) 2003-08-20
AR025923A1 (es) 2002-12-18
JP2003510275A (ja) 2003-03-18
WO2001022955A2 (de) 2001-04-05
BR0014312B1 (pt) 2012-09-04
ES2199868T3 (es) 2004-03-01
TWI224968B (en) 2004-12-11
CA2387398C (en) 2009-05-12
CZ295090B6 (cs) 2005-05-18
EE200200146A (et) 2003-04-15
AU7907300A (en) 2001-04-30
BR0014312A (pt) 2002-05-21
HUP0202862A3 (en) 2003-10-28
WO2001022955A3 (de) 2001-05-17
JP5524438B2 (ja) 2014-06-18
EE04997B1 (et) 2008-04-15
DK1216046T3 (da) 2003-09-29
DE50002478D1 (de) 2003-07-10
CA2387398A1 (en) 2002-03-28
CZ20021014A3 (cs) 2002-06-12
HU229606B1 (en) 2014-02-28
JP2012001558A (ja) 2012-01-05
EP1216046A2 (de) 2002-06-26

Similar Documents

Publication Publication Date Title
HUP0202862A2 (hu) A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
HUP0003848A2 (hu) Budesonid és formoterol új alkalmazása
HUP0303083A2 (hu) CETP-gátló és atorvasztatin terápiás kombinációját tartalmazó gyógyszerkészítmények és alkalmazásuk
SI1509232T1 (sl) Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni
HUP9903905A2 (hu) Kombinált terápia az elmezavarok kezelésére
HUP0301281A2 (hu) Új gyógyászati készítmény
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
HUP0401191A2 (hu) Opioid agonistát, valamint leadható és álcázott antagonistát tartalmazó készítmények
HUP0202570A1 (hu) Izoflavonokat és analogonjait tartalmazó készítmények és terápiás alkalmazásuk
HUP0203556A2 (hu) Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0002316A2 (hu) Gyorsan olvadó orális adagolási formák
HUP0401978A2 (hu) Tamszulozintabletták
HUP0001527A2 (hu) Laktózmentes, nem higroszkópos és vízmentes dekarboetoxiloratadin-tartalmú gyógyászati készítmények
HUP0103108A2 (hu) Formoterolt és budesonidot tartalmazó készítmény alkalmazása asztma akut állapotának megelőzésére
TW200626526A (en) Pharmaceutical compositions for the treatment of neoplasms
YU37602A (sh) Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
HUP0401998A2 (hu) PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető
HUP0300426A2 (hu) Antihipertenzív és anti-angiogén szerek terápiás kombinációja és ezeket tartalmazó gyógyszerkészítmények
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
IL168308A (en) Compositions containing roflumilast and formoterol
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
MXPA04003611A (es) Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
UA42719C2 (uk) Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: MEDA PHARMA GMBH & CO. KG, DE

Free format text: FORMER OWNER(S): VIATRIS GMBH & CO. KG, DE; VIATRIS GMBH & CO. KG, DE

MM4A Lapse of definitive patent protection due to non-payment of fees